Global Ring Study to Investigate the Comparability of Total Assay Performance of Commercial Claudin 18 Antibodies for Evaluation in Gastric Cancer-Reference-Cited by-同舟云学术

Global Ring Study to Investigate the Comparability of Total Assay Performance of Commercial Claudin 18 Antibodies for Evaluation in Gastric Cancer

Published:2024-01 Issue:1 Volume:104 Page:100284
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Laboratory Investigation

Author:

Jasani Bharat,Taniere Philippe,Schildhaus Hans-Ulrich,Blighe Kevin,Parry Suzanne,Wilkinson Dawn,Atkey Neil,Clare-Antony Scott,McCabe Clare,Quinn Christine^ORCID,Dodson Andrew,Gibney Steven

Funder

Astellas Pharma

Astellas Pharma Inc

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Reference46 articles.

1. Burden of gastric cancer;Thrift;Clin Gastroenterol Hepatol,2020

2. Gastric cancer;Van Cutsem;Lancet,2016

3. Progress in gastric cancer;Strong;Updates Surg,2018

4. Emerging novel therapeutic agents in the treatment of patients with gastroesophageal and gastric adenocarcinoma;Anandappa;Hematol Oncol Clin North Am,2017

5. Recent estimates and predictions of 5-year survival in patients with gastric cancer: a model-based period analysis;Li;Cancer Control,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Claudin-18.2 Immunohistochemical Evaluation in Gastric and Gastroesophageal Junction Adenocarcinomas to Direct Targeted Therapy: A Practical Approach;Modern Pathology;2024-11

2. Extent and clinical significance of the therapy-relevant tight junction protein Claudin 18.2 in pancreatic ductal adenocarcinoma - real-world evidence;Translational Oncology;2024-09

3. PD-L1 Immunohistochemistry in Gastric Cancer: Comparison of Combined Positive Score and Tumor Area Positivity Across 28-8, 22C3, and SP263 Assays;JCO Precision Oncology;2024-07

4. Incorporating Molecular Data Into Treatment Decision Making in Gastroesophageal and Pancreaticobiliary Cancers: Timing and Strategies;American Society of Clinical Oncology Educational Book;2024-06

5. High Expression of CLDN 18.2 is Associated with Poor Disease-Free Survival of HER-2 Positive Gastric Cancer;International Journal of General Medicine;2024-04